🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Pediatric Central Nervous System Tumor

Intensity Modulated PrOton Therapy in Pediatric BRain Tumors (IMPORT) NCT07338526NA1 site📍 Mumbai Tata Memorial Centre · Tests: Intensity-modulated proton therapy (IMPT), Photon-based intensity-modulated radiation therapy (IMRT). Targeted Oligometastatic Radiation in Pediatric and Young Adult Patients With Soft Tissue and Bone Sarcoma NCT06796543NA3 sites📍 Washington D.C.📍 Baltimore📍 Minneapolis Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · Tests: Consolidative radiation therapy (cRT) Genetic and Molecular Risk Profiles of Pediatric Malignant Brain Tumors in China NCT05672043n/a1 site📍 Beijing Beijing Tiantan Hospital MICRO-BRAIN 2024: Study on Pediatric Brain Tumors NCT07417085NA1 site📍 Florence Meyer Children's Hospital IRCCS · Tests: Biological samples, Fecal samples Open-label, Long-term Safety, Efficacy, and Pharmacokinetics Study of Vibegron in Pediatric Subjects 2 Years to < 18 Years of Age With NDO and on CIC NCT05491525Phase 2, Phase 338 sites📍 Little Rock📍 Orange📍 Aurora Urovant Sciences GmbH · Tests: Vibegron Radiation Induced Alterations in Resting State Brain Networks in Pediatric Brain Tumor Patients NCT06185686n/a1 site📍 St Louis Washington University School of Medicine · Tests: Cognitive testing, Resting State MRI/Precision functional mapping Genetic and Electrophysiologic Study in Focal Drug-resistant Epilepsies NCT02890641n/a1 site📍 Paris Fondation Ophtalmologique Adolphe de Rothschild · Tests: Sampling of blood, frozen resected tissues, and cerebrospinal fluid (CSF) Engineering Immune Organoids to Study Pediatric Cancer NCT05890781NA2 sites📍 Villejuif📍 Paris Gustave Roussy, Cancer Campus, Grand Paris · Tests: Skin biopsy, Fresh tumor sample, Blood sample, Healthy tissue from the tumor, Spinal cerebrospinal fluid (SCF) Lithium Treatment to Prevent Cognitive Impairment After Brain Radiotherapy NCT06051240Phase 22 sites📍 Solna📍 Stockholm Region Stockholm · Tests: Lithium, Placebo Engineered HSV-1 M032 for the Treatment of Children and Adults With Newly Diagnosed Diffuse Midline Glioma After Standard of Care Radiation NCT07076498Phase 11 site📍 Houston M.D. Anderson Cancer Center · Tests: M032 HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors NCT03911388Phase 13 sites📍 Birmingham📍 St Louis📍 Houston M.D. Anderson Cancer Center · Tests: G207 Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells NCT07148050Phase 11 site📍 Seattle Seattle Children's Hospital · Tests: SC-CAR.GPC3xIL15.21 CAR T cells Utility of PET-MRI in Surveillance of Paediatric Brain Tumours NCT05553899NA1 site📍 Sheffield Sheffield Children's NHS Foundation Trust · Tests: PET-MRI Somatic Mosaicism in Twins Discordant for Childhood Cancer NCT06054295n/a1 site📍 Minneapolis Children's Oncology Group · Tests: Biospecimen collection, Questionnaire Administration Molecular Analysis of Samples From Patients With Diffuse Intrinsic Pontine Glioma and Brainstem Glioma NCT01106794n/a1 site📍 Washington D.C. Children's National Research Institute Immunotherapy for Malignant Pediatric Brain Tumors Employing Adoptive Cellular Therapy (IMPACT) NCT06193759Phase 11 site📍 Washington D.C. Children's National Research Institute · Tests: Multi-tumor antigen specific cytotoxic T lymphocytes (TSA-T) directed against proteogenomically determined personalized… Virus-Based Gene Therapy (AdV-HSV1-TK and AdV-Flt3L) in Combination With Valacyclovir for the Treatment of Pediatric and Young Adult Patients With Resectable, Recurrent Primary Malignant Brain Tumors NCT06914479Phase 11 site📍 Ann Arbor University of Michigan Rogel Cancer Center · Tests: Ad-hCMV-Flt3L, Ad-hCMV-TK, Biospecimen Collection, Magnetic Resonance Imaging, Survey Administration Safety Study of the Repeated Opening of the Blood-brain Barrier With the SonoCloud® Device to Treat Malignant Brain Tumors in Pediatric Patients NCT05293197Phase 13 sites📍 Paris📍 Paris📍 Villejuif Assistance Publique - Hôpitaux de Paris · Tests: SonoCloud® (9 transducers) Efficacy of a Smart Holistic Health Care Platform Intervention on Cancer Children and Parents' Bio-Psycho-Social and Spiritual Health NCT07805096NA1 site📍 Taipei National Defense Medical University, Taiwan · Tests: Parent Smart Holistic Health Care Platform (P-SHHCP), Child Smart Holistic Health Care Platform (C-SHHCP) Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant NCT05843253Phase 220 sites📍 Aurora📍 Washington D.C.📍 Chicago Nationwide Children's Hospital · Tests: Ribociclib, Everolimus, Temozolomide (TMZ) Hospital and Home Rehabilitation Based on Social Care Robotics and Artificial Intelligence for Pediatric Patients NCT07448103NA1 site📍 Madrid Inrobics Social Robotics, S.L. · Tests: Robot-assisted, gamified pediatric upper-limb rehabilitation (hybrid clinic + home program) A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations NCT04094610Phase 1, Phase 268 sites📍 Los Angeles📍 Los Angeles📍 Aurora Turning Point Therapeutics, Inc. · Tests: Oral repotrectinib (TPX-0005) Pediatric Radiation Therapy Registry NCT07129317n/a2 sites📍 Washington D.C.📍 Baltimore Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Dexmedetomidine Use for Greater Occipital Nerve Block in Pediatric Posterior Fossa Tumor Surgery. NCT07878156Phase 31 site📍 Cairo Children's Cancer Hospital Egypt 57357 · Tests: Bupivacaine 0.25%, Dexmedetomidine 1mcg/kg, Blind greater occipital nerve block, Ultrasound-guided greater occipital ne… Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG). NCT07680439Phase 26 sites📍 Los Angeles📍 Atlanta📍 Chicago BrainChild Bio, Inc · Tests: BCB-276 Intratumoral DNX-2401 for High Grade Pediatric Brain Tumors NCT07424092Phase 22 sites📍 Utrecht📍 Pamplona Clinica Universidad de Navarra, Universidad de Navarra · Tests: DNX-2401 GD2-CAR T Cells for Pediatric Brain Tumours NCT05298995Phase 11 site📍 Roma Bambino Gesù Hospital and Research Institute · Tests: GD2-CART01 (iC9-GD2-CAR T-cells) Study of CAR T-Cells Targeting the GD2 With IL-15+iCaspase9 for Relapsed/Refractory Neuroblastoma or Relapsed/Refractory Osteosarcoma NCT03721068Phase 12 sites📍 Atlanta📍 Chapel Hill UNC Lineberger Comprehensive Cancer Center · Tests: iC9.GD2.CAR.IL-15 T-cells, Cyclophosphamide, Fludarabine Systematic Light Exposure in Pediatric Brain Tumor Survivors NCT05340881NA1 site📍 Houston Baylor College of Medicine · Tests: Bright Light Exposure, Dim Light Exposure, Cognitive Assessment Cerebellar Mutism Syndrome Study NCT02300766n/a32 sites📍 Vienna📍 Leuven📍 Prague Copenhagen University Hospital, Rigshospitalet
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy